Speakers

C.P. Shastry is a Research Pharmacist with post- graduate qualifications in pharmacy and business management.
He has over 35 years experience in international pharmaceutical industry, as a working professional and consultant.
He manages independently Pharma Synergies, which is an International Strategic Pharma Business Development Consultancy & Market Research Organization.
C. P. Shastry has been making presentations on strategic topics related to global pharmaceutical industry' in international forums in Asia, Africa, Europe, Middle East and North America, including in CPhI Events, and business schools.
Pharma Synergies vision is to facilitate synergies between global & regional pharmaceutical industries and to disseminate knowledge among the stakeholders of global pharmaceutical industry, for affordable and easy access to healthcare.

Mr. Reiner Christensen looks back on more than 20 years of substantial international experience in Rx, Medical Device, Clinic, OTC, Derma/Cosmetic and Food Supplements products in General Management. He has previously worked for Ferrosan A/B (Copenhagen), Omega Pharma Group (Brussels) and Merck KGaA (Asia, Latin America, Europe & CEE/CIS), Hoechst AG(Frankfurt) and Richard Bittner AG (Vienna). Reiner has lived and worked in Asia, Russia/CIS, Latin America and different European countries. His current focus in the Chameleon Pharma Consulting Group is on international Market Entry, Strategy, Marketing, Business Development, Regulatory and M&A. Reiner holds a Diploma in Industrial Engineering & Management (Dipl. Wirtschaftsingenieur) and an Executive MBA from Ashridge.

Pete Gagnon is a widely respected global authority in the field of downstream processing. He is the author or more than 100 scientific publications and inventor on more than 100 awarded patents in the United States, Europe, and Asia. His expertise covers purification of monoclonal antibodies, virus particles, extra-cellular vesicles, plasmid DNA, and mRNA. He is currently Chief Scientific Officer at BIA Separations, a European manufacturer of specialized chromatography media for purification of gene therapy products.

Dr. Mandakini Goel has a PhD in pharmaceutical science with 12+ years of experience in pharmaceutical research and development, academia, and corporate. Currently, she is working as Lead, Life Science Consulting Services and Senior Solution Consultant with Clarivate Analytics, handling solution management and providing value proposition of life sciences and intellectual property related products and services, across South Asia business.

She also drives thought leadership activities to ensure client engagement and drive innovation at both industry and academia. She is also responsible for providing on-site and virtual support (pre-sales and post-sales) to alleviate any challenge in understanding generics market space, designing market launch strategies, IP strategies and building product portfolio.

Anders Henriksson PhD
Application and Technical Support Leader, APAC
Probiotics, HMO and Fibers
DuPont Nutrition & Biosciences
Based in Australia, Anders supports DuPont products and research projects in related to dietary supplements, health and nutrition throughout the Asia Pacific Region. Anders joined Danisco in 2008 as a senior scientist based in Singapore, where he led several development projects related to culture formulations for dairy and dietary supplement products. Before that he worked as a scientist with a major international food ingredients organisation, where he was involved in culture development and pre-clinical and clinical studies on probiotics and prebiotics. He has a PhD in microbiology from the University of Gothenburg, Sweden and completed postdoctoral research in the field of gastrointestinal microbiology at Australia’s University of New South Wales.

Experience:
- He is Pharmacist by profession who studied at the University of Santo Tomas in Manila, Philippines.
- Joined Rudolf Lietz Inc - chemical trading company - for 10 years, initially as Technical sales person who looks after the major principals like Colorcon, DFE, Pharmazell and other European suppliers.
- He is the Senior Area Technical Manager and a Business Development Manager of Colorcon Asia pacific Pte Ltd for AP06 territory

Richard M. Johnson has been the President and Chief Executive Officer of the Parenteral Drug Association since September 2009. In this position he has grown PDA globally and focused the organization on Science & Regulatory contributions. Richard has been an active member of PDA for more than 25 years, serving on the Scientific Advisory Board (co-chair); Regulatory Affairs & Quality Control committee; Sterile/Aseptic Processing Interest Group (chair); Aseptic Processing committee (co-chair); GMP and Glass Defects (Chair) Task Forces.

In his 40-year career in the pharmaceutical and medical devices industry, with responsible for facilities throughout US, Europe, Asia and South America, Richard has been a recognized leader with excellent knowledge of US and international regulatory requirements, quality practices, and technical operations, especially in validation, sterilization, aseptic and sterile processing.

Prior positions include Vice President of Global Quality Assurance for Fort Dodge Animal Health (a division of Wyeth), Director of the Corporate Quality Center of Excellence for Abbott Laboratories, and both US and International assignments with Alcon Laboratories and Bausch & Lomb. Richard has M.Sc. and B.Sc. degrees in Biological Sciences from Marshall University. He was also the co- chair of the US Sub-TAG to ISO/TC 198 (Aseptic Processing), and has been active in the PhRMA Bar Code Committee, PQRI Aseptic Processing Working Group, ISPE and the Midwest Quality Discussion Groups since the early 1990’s.

Dr. Sunil Kaul was born and brought up in Kalimpong (Darjeeling), India. He obtained his MPhil and PhD degrees from the University of Delhi, India. After his initial post-doctoral training, he was appointed as a researcher at the National Institute of Advanced Industrial Science & Technology (AIST) in Japan, and has been working there for last 30 years. He is now a Chief Senior Research Scientist. His major research interest is to understand the molecular mechanism of stress, aging and cancer. He has been merging the traditional knowledge with modern technologies like gene silencing and imaging to understand the mechanism of action of Ayurvedic herb, Ashwagandha and others. With more than 200 research publications in International peer revised journals and several invited talks Internationally, he has been in Editorial board of several scientific journals. He is a Fellow of Geriatrics Society of India (FGSI), Overseas Fellow of Biotech Research Society of India (FBRSI), Fellow of Indian Academy of Neuroscience (FIAN), and Foreign Fellow of National Academy of Sciences, India (FNASc).

• Dr. Radhakrishnanand possesses around 19 years of experience in Analytical department at various capacities and worked in the regulatory environment throughout the career. He worked for United States Pharmacopeia (USP), GVK Bio and Dr. Reddy Laboratories where he successfully accomplished projects on analytical method development and validations for raw materials, intermediates, API and finished products. He has sound knowledge in Chiral Chromatography and various Hyphenated techniques. His expertise also extends to quality assurance and laboratory management. In his current role at Daicel Chiral Technologies-India, he is responsible for Business development of Daicel products and services in India and South East Asian regions.
• He has delivered USP General Chapters in various user forums and conferences. He has authored more than 25 peer reviewed scientific publications and presented posters in professional conferences. He is reviewer for international journals like Analytical papers, ACTA Chromatographica, AJAC. He earned his Ph.D. in analytical chemistry from Jawaharlal Nehru Technological University, Hyderabad and obtained MBA degree in Technology management with Marketing as specialization from Osmania University, Hyderabad.

Past Experience 1996 – 2002 General Surgeon at Bhumibol Adulyadej Hospital/ 1998-1999 Secretariat and member of Trauma Sub-Committee, Royal Thai College of Surgeon/ 2014-2015 Member of Board Director, National Cancer Institute /2013 – 2016 Assistant Director for Research and Special Activity, National Cancer Institute/ 2017– 2018 Director of Medical Of?ce Region 5, Department of Medical Services, MOPH/ 2018-2019 Deputy Director of Academic and Medical Division, National Cancer Institute

2012, Outstanding Award of Poster presentation on Biopharmaceutical Sciences entitle of “Study on a relationship between nitric oxide levels and cognitive behaviors in rats”. The 28th International Annual Meeting in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Chulalongkorn University.

2013, Outstanding Award of Poster presentation on Biopharmaceutical Sciences entitle of “Effect of 21-day administration of spinach on operant conditioning behavior-related learning and memory in rats”. The 29th International Annual Meeting in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Chulalongkorn University.
2013. Outstanding staff of the Ministry of Science and Technology in 2012. Ministry of Science and Technology, Thailand.

2016, Outstanding Award of Poster presentation entitle of “Effect of chrysanthemum flower extract on analgesia and serotonin levels associated with migraine symptoms in rats. The 32nd International Annual Meeting in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Chulalongkorn University.

Dr. Renu Wadhwa had her first PhD from the Guru Nanak Dev University, India and the second PhD from the University of Tsukuba, Japan. She had her post-doctoral trainings at the University of Newcastle Upon Tyne, England and RIKEN, Japan. She has been working in Japan for last 29 years and has been leading a research team working on the mechanisms of cell proliferation controls at the Biomedical Research Institute, AIST, Japan. Her major research interest is to understand the molecular mechanism of aging and cancer using normal and cancer cells as model system. She had first cloned a novel member of hsp70 family protein in 1993 and named it “mortalin”. Since then she has made several original findings describing the functional characteristics of this protein and its role in cancer and age-related disorders. She has more than 200 publications in International peer reviewed journals with many invited/plenary talks in international conferences. She has served as a member of AACR (1997-2000) and President of 86th Annual meeting of Japanese Tissue Culture Association at AIST Tsukuba, and is a leader of DBT-AIST International Laboratory for Advanced Biomedicine (DAILAB) at AIST, Japan. She has been in Editorial board of several scientific journals including Journal of Gerontology: Biological Sciences and Mechanism of Ageing and Development. As honorary academic positions, she has served as an Associate Professor at the University of Tokyo, Professor at the Yonsei University College of Medicine (Seoul). She is a Fellow of Geriatric Society of India, Indian Academy of Neurosciences, Biotech Research Society, India and Foreign Fellow of National Academy of Sciences (India).